flucytosine has been researched along with valganciclovir in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brown, S; DePeralta-Venturina, M; Freytag, SO; Kim, JH; Lu, M; Paielli, D; Peabody, J; Pegg, J; Pradhan, DG; Stricker, H; Xia, X | 1 |
| Aref, I; Barton, KN; Brown, SL; Elshaikh, M; Freytag, SO; Karvelis, KC; Kim, JH; Lu, M; Movsas, B; Pegg, J; Siddiqui, F; Stricker, H; Zhang, Y | 1 |
| Barton, K; Freytag, SO; Kim, JH; Lu, M; Movsas, B; Stricker, H | 1 |
| Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
2 review(s) available for flucytosine and valganciclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
3 trial(s) available for flucytosine and valganciclovir
| Article | Year |
|---|---|
Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer.
Topics: Adenoviruses, Human; Aged; Aged, 80 and over; Combined Modality Therapy; Cytosine Deaminase; DNA, Viral; Flucytosine; Ganciclovir; Gene Expression; Genetic Therapy; Humans; Male; Middle Aged; Prostatic Neoplasms; Recombinant Fusion Proteins; Simplexvirus; Thymidine Kinase; Transgenes; Valganciclovir; Virus Replication | 2003 |
Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate.
Topics: Adenoviridae; Aged; Cohort Studies; Flucytosine; Ganciclovir; Gene Expression; Genetic Vectors; Humans; Male; Middle Aged; Prostate; Tomography, Emission-Computed, Single-Photon; Valganciclovir | 2008 |
Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial).
Topics: Adenoviridae; Antimetabolites; Antiviral Agents; Combined Modality Therapy; Flucytosine; Ganciclovir; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Humans; Kaplan-Meier Estimate; Male; Prostatic Neoplasms; Quality of Life; Radiotherapy, Intensity-Modulated; Sample Size; Treatment Outcome; Valganciclovir; Virus Replication | 2011 |